Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B421b31406c3bdf1dae2acb7d325fbfd9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B421b31406c3bdf1dae2acb7d325fbfd9 NCIT_P378 "NCI" @default.
- B421b31406c3bdf1dae2acb7d325fbfd9 type Axiom @default.
- B421b31406c3bdf1dae2acb7d325fbfd9 annotatedProperty IAO_0000115 @default.
- B421b31406c3bdf1dae2acb7d325fbfd9 annotatedSource NCIT_C173363 @default.
- B421b31406c3bdf1dae2acb7d325fbfd9 annotatedTarget "An episcleral plaque containing sustained-release (SR) topotecan, a semisynthetic derivative of camptothecin and a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminate, with potential antineoplastic activity. Upon local application of the topotecan SR episcleral plaque to the eye, topotecan is released in a sustained manner and inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. The episcleral plaque allows for local delivery of topotecan for the potential treatment of retinoblastoma." @default.